|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2007-8-20
|
|
pubmed:abstractText |
This phase I trial (EGF10005) assessed the safety, optimally tolerated regimen (OTR), and pharmacokinetics of lapatinib and capecitabine in combination in patients with advanced solid malignancies.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AryaNikitaN,
pubmed-author:ChuQuincy S CQS,
pubmed-author:CurtrightJanJ,
pubmed-author:FlemingRonald ARA,
pubmed-author:HoPeter T CPT,
pubmed-author:KochKevin MKM,
pubmed-author:PanditeLiniL,
pubmed-author:RowinskyEric KEK,
pubmed-author:SchwartzGarryG,
pubmed-author:SmithDeborah ADA,
pubmed-author:VersolaMelissa JMJ,
pubmed-author:de BonoJohannJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3753-8
|
|
pubmed:meshHeading |
pubmed-meshheading:17704424-Adolescent,
pubmed-meshheading:17704424-Adult,
pubmed-meshheading:17704424-Aged,
pubmed-meshheading:17704424-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17704424-Child,
pubmed-meshheading:17704424-Child, Preschool,
pubmed-meshheading:17704424-Deoxycytidine,
pubmed-meshheading:17704424-Drug Administration Schedule,
pubmed-meshheading:17704424-Fluorouracil,
pubmed-meshheading:17704424-Humans,
pubmed-meshheading:17704424-Maximum Tolerated Dose,
pubmed-meshheading:17704424-Middle Aged,
pubmed-meshheading:17704424-Neoplasms,
pubmed-meshheading:17704424-Quinazolines
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies.
|
|
pubmed:affiliation |
Institute for Drug Development, Cancer Therapy and Research Center, San Antonio, TX, USA. quincchu@cancerboard.ab.ca
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase I
|
